Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.

Blood cells, molecules & diseases - 1 Jan 2000

Goldstein J A, Blaisdell J A, Limdi N A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases
Share to Atrial Fibrillation
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comorbidity

Share to Cytochrome P-450 CYP2C9

Share to Gastrointestinal Hemorrhage

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 19083245
DOI: 10.1016/j.bcmd.2008.10.011
PMCID: PMC2662477

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.PMID 19083245Read ↗

A novel CYP2C9 variant that caused erroneous genotyping in a patient on warfarin therapy.Semantic proximity Read ↗

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.Semantic proximity Read ↗

A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.Semantic proximity Read ↗

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects.Semantic proximity Read ↗

Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity.Semantic proximity Read ↗

Pharmacogenetics of Novel Oral Anticoagulants: A Review of Identified Gene Variants & Future PerspectivesSemantic proximity Read ↗

Genetic susceptibility to hemorrhagic complications during warfarin therapy.Semantic proximity Read ↗

Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.Semantic proximity Read ↗

VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.Semantic proximity Read ↗

Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual.Semantic proximity Read ↗

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.Semantic proximity Read ↗

Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.